You are here

FSD Pharma Takes the Spotlight in CNBC's Cannabis Coverage -- CFN Media

SEATTLE, Wash., Oct. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing FSD Pharma Inc. (CSE: HUGE), (OTCQB: FSDDF), (FRA: 0K9). In this article, we will take a closer look at the company, its recent CNBC coverage, and where it’s headed over the coming quarters.

Canada is set to become the first G7 nation to legalize recreational cannabis and international beverage brands are salivating at the possibilities. Constellation Brands Inc. doubled down on its investment in Canopy Growth Corp., Molson Coors Brewing Co. signed a joint venture with The Hydropothecary Corp., and even Coca-Cola Co. has taken an interest in the space.

CNBC has ramped up its coverage of the space ahead of Canada’s recreational legalization in less than a month. On September 21, the go-to news source for investors profiled the industry both online and on television. The television producers chose to focus on FSD Pharma Inc. and visited its Cobourg plant. The location and personnel were featured four times during the day, each with a different area of focus.

Becoming an Industry Leader

FSD Pharma’s renovated 70-acre Kraft facility could become the world’s largest hydroponic cannabis farm, located just one hour east of Toronto. The current 25,000 sq. ft. facility has an annual production capacity of 4,000 kilograms, but management plans to expand to nearly 3.9 million sq. ft. in a two-stage expansion. This would put it just behind Canopy Growth and Aurora Cannabis in terms of square footage—at a fraction of their valuation.

Management plans to focus on the medical market as soon as they obtain a sellers’ license, saying that there could be a shortage as other licensed producers move into the recreational market where demand is projected to be initially higher. These dynamics could put a significant premium on medical versus recreational products. Margins from greenhouse strains are also expected to outpace outdoor cannabis products.

CNBC Coverage Raises Profile

The first of the four segments introduces the upcoming Canadian cannabis legalization milestone and features a brief walkthrough of FSD Pharma’s facility. The second segment features an interview with Director Anthony Durkacz. The third segment features a further walkthrough of its facility in Ontario. And, the fourth segment features an extended interview with Anthony on CNBC’s widely watched Power Lunch segment.

The live CNBC coverage bolsters the company’s credibility in the space, particular given the rising number of development-stage licensed producers that can make it challenging for investors to sort true opportunities from hype. Often times, companies featured on CNBC experience higher-than-average trading volume and may be added to important investor watchlists as credible opportunities in the space.

Looking Ahead

FSD Pharma Inc. (CSE: HUGE) ( OTCQB: FSDDF) (FRA: 0K9) represents a compelling investment opportunity in Canada’s burgeoning cannabis sector. In addition to its massive indoor facility, the company’s strategic investments and partnerships across the industry are paving the way for research, development, and distribution throughout the country and around the world.

When asked whether cannabis stocks were in a bubble, Mr. Durkacz drew a comparison to the Internet bubble, telling CNBC, “We are in a bubble — but we were in an internet bubble in 1998 that continued for another few years — if you did not make an investment in 1998, you missed a lion’s share of what could be earned in terms of return on investment.”

Investors that want to buy into the cannabis industry at an early stage may want to take a closer look at the company given its exposure on CNBC, it’s existing license and production capacity, and its unique focus on the medical market.

For more information, visit the company’s website at www.fsdpharma.com.

Please follow the link to read the full article: http://www.cannabisfn.com/fsd-pharma-takes-spotlight-cnbcs-cannabis-coverage/.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/.

About CFN Media

CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.

Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany.

Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8.

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com.

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.  

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/.

Frank Lane
206-369-7050
Flane@cannabisfn.com   

Friday, October 5, 2018 - 09:00